Home
>
National Drug Code (NDC)
>
Intuniv
Intuniv - 54092-513-02 - (guanfacine)
Drug Information of Intuniv
| Product NDC: | 54092-513 |
| Proprietary Name: | Intuniv |
| Non Proprietary Name: | guanfacine |
| Active Ingredient(s): | 1 mg/1 & nbsp; guanfacine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Intuniv
| Product NDC: | 54092-513 |
| Labeler Name: | Shire US Manufacturing Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022037 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090902 |
Package Information of Intuniv
| Package NDC: | 54092-513-02 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-513-02) |
NDC Information of Intuniv
| NDC Code | 54092-513-02 |
| Proprietary Name | Intuniv |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-513-02) |
| Product NDC | 54092-513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | guanfacine |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090902 |
| Marketing Category Name | NDA |
| Labeler Name | Shire US Manufacturing Inc. |
| Substance Name | GUANFACINE HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
